Imaging‐Guided Microarray

Abstract:  Although both Alzheimer's disease (AD) and normal aging contribute to age‐related hippocampal dysfunction, they are likely governed by separate molecular mechanisms. In principle, gene expression profiling can offer molecular clues about underlying mechanisms, but in practice techniques like microarray present unique analytic challenges when applied to disorders of the brain. Imaging‐guided microarray is an approach designed to address these analytic challenges. Here, we will first review findings applying variants of functional magnetic resonance imaging (fMRI) to AD and normal aging, establishing the spatiotemporal profiles that dissociate one from the other. Then, we will review preliminary findings applying imaging‐guided microarray to AD and normal aging, in an attempt to isolate molecular profiles that dissociate the two main causes of age‐related hippocampal dysfunction.

[1]  P F Renshaw,et al.  Dynamic susceptibility contrast MR imaging of regional cerebral blood volume in Alzheimer disease: a promising alternative to nuclear medicine. , 1998, AJNR. American journal of neuroradiology.

[2]  S A Small,et al.  Evaluating the function of hippocampal subregions with high‐resolution MRI in Alzheimer's disease and aging , 2000, Microscopy research and technique.

[3]  Mark R. Segal,et al.  Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death , 2004, Nature.

[4]  J. D. McGaugh,et al.  Inhibition of Activity-Dependent Arc Protein Expression in the Rat Hippocampus Impairs the Maintenance of Long-Term Potentiation and the Consolidation of Long-Term Memory , 2000, The Journal of Neuroscience.

[5]  S. Small,et al.  Brain Microarray: Finding Needles in Molecular Haystacks , 2005, The Journal of Neuroscience.

[6]  S. Small.  Measuring Correlates of Brain Metabolism With High-Resolution MRI: A Promising Approach for Diagnosing Alzheimer Disease and Mapping Its Course , 2003, Alzheimer disease and associated disorders.

[7]  Ed X. Wu,et al.  Imaging Physiologic Dysfunction of Individual Hippocampal Subregions in Humans and Genetically Modified Mice , 2000, Neuron.

[8]  L. Honig,et al.  Model‐guided microarray implicates the retromer complex in Alzheimer's disease , 2005, Annals of neurology.

[9]  Joseph D. Terwilliger,et al.  Gene Mapping in the 20th and 21st Centuries: Statistical Methods, Data Analysis, and Experimental Design , 2009, Human biology.

[10]  S. Small.  Alzheimer disease, in living color , 2005, Nature Neuroscience.

[11]  C. Arighi,et al.  Role of the mammalian retromer in sorting of the cation-independent mannose 6-phosphate receptor , 2004, The Journal of cell biology.

[12]  M. Seaman.  Cargo-selective endosomal sorting for retrieval to the Golgi requires retromer , 2004, The Journal of cell biology.

[13]  A. Burlingame,et al.  The mammalian retromer regulates transcytosis of the polymeric immunoglobulin receptor , 2004, Nature Cell Biology.

[14]  P. Brown,et al.  Exploring the metabolic and genetic control of gene expression on a genomic scale. , 1997, Science.

[15]  Hui Lu,et al.  Correlation between gene expression profiles and protein-protein interactions within and across genomes , 2005, Bioinform..

[16]  Carol A Barnes,et al.  Imaging correlates of brain function in monkeys and rats isolates a hippocampal subregion differentially vulnerable to aging. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[17]  H. Braak,et al.  Evolution of the neuropathology of Alzheimer's disease , 1996, Acta neurologica Scandinavica. Supplementum.

[18]  T. Ohm,et al.  Spatial and temporal relationships between plaques and tangles in Alzheimer-pathology , 2004, Neurobiology of Aging.

[19]  D. Selkoe.  Alzheimer's Disease Is a Synaptic Failure , 2002, Science.

[20]  M. J. Wade,et al.  Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease. , 2001, Archives of neurology.

[21]  E F Halpern,et al.  Functional MR in the evaluation of dementia: correlation of abnormal dynamic cerebral blood volume measurements with changes in cerebral metabolism on positron emission tomography with fludeoxyglucose F 18. , 1995, AJNR. American journal of neuroradiology.

[22]  Quantifying cerebral blood flow: regional regulation with global implications. , 2004, The Journal of clinical investigation.

[23]  S. Small,et al.  Age-related memory decline: current concepts and future directions. , 2001, Archives of neurology.

[24]  G. Small,et al.  Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease. , 2002, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[25]  Yaakov Stern,et al.  Imaging hippocampal function across the human life span: Is memory decline normal or not? , 2002, Annals of neurology.

[26]  P. Lantos,et al.  Neuronal loss and neurofibrillary degeneration in the hippocampal cortex in late‐onset sporadic Alzheimer's disease , 2000, Psychiatry and clinical neurosciences.

[27]  W. Dauer,et al.  Parkinson's Disease Mechanisms and Models , 2003, Neuron.

[28]  Wanpin Chang,et al.  GGA Proteins Mediate the Recycling Pathway of Memapsin 2 (BACE)* , 2005, Journal of Biological Chemistry.

[29]  R. Floris,et al.  Diffusion and perfusion MR imaging in cases of Alzheimer's disease: correlations with cortical atrophy and lesion load. , 2001, AJNR. American journal of neuroradiology.

[30]  J. Morrison,et al.  Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s disease , 2003, Neurology.

[31]  M. Reiser,et al.  MR measurement of regional relative cerebral blood volume in epilepsy , 1999, Journal of magnetic resonance imaging : JMRI.